Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2299 entries
Sorted by: Best Match Show Resources per page
Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report.

Journal of medical case reports

Cheungpasitporn W, Jirajariyavej T, Howarth CB, Rosen RM.
PMID: 21831272
J Med Case Rep. 2011 Aug 10;5:364. doi: 10.1186/1752-1947-5-364.

INTRODUCTION: Henoch-Schönlein purpura is the most common systemic vasculitis in children. Typical presentations are palpable purpura, abdominal pain, arthritis, and hematuria. This vasculitic syndrome can present as an uncommon cause of rectal bleeding in older patients. We report a...

Cite
Cheungpasitporn W, Jirajariyavej T, Howarth CB, et al. Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. J Med Case Rep. 2011;5:364doi: 10.1186/1752-1947-5-364.
Cheungpasitporn, W., Jirajariyavej, T., Howarth, C. B., & Rosen, R. M. (2011). Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. Journal of medical case reports, 5364. https://doi.org/10.1186/1752-1947-5-364
Cheungpasitporn, Wisit, et al. "Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report." Journal of medical case reports vol. 5 (2011): 364. doi: https://doi.org/10.1186/1752-1947-5-364
Cheungpasitporn W, Jirajariyavej T, Howarth CB, Rosen RM. Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report. J Med Case Rep. 2011 Aug 10;5:364. doi: 10.1186/1752-1947-5-364. PMID: 21831272; PMCID: PMC3163221.
Copy Download .nbib Format: NLM
In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism.

Cartilage

Sherman SL, Khazai RS, James CH, Stoker AM, Flood DL, Cook JL.
PMID: 26425261
Cartilage. 2015 Oct;6(4):233-40. doi: 10.1177/1947603515594453.

OBJECTIVE: There is growing concern that intra-articular injection of local anesthetic and/or corticosteroids may cause significant morbidity, including potential toxicity to chondrocytes and synoviocytes, after even a single exposure. We demonstrate that full thickness canine chondral and synovial samples...

Cite
Sherman SL, Khazai RS, James CH, et al. In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism. Cartilage. 2015;6(4):233-40doi: 10.1177/1947603515594453.
Sherman, S. L., Khazai, R. S., James, C. H., Stoker, A. M., Flood, D. L., & Cook, J. L. (2015). In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism. Cartilage, 6(4), 233-40. https://doi.org/10.1177/1947603515594453
Sherman, Seth L, et al. "In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism." Cartilage vol. 6,4 (2015): 233-40. doi: https://doi.org/10.1177/1947603515594453
Sherman SL, Khazai RS, James CH, Stoker AM, Flood DL, Cook JL. In Vitro Toxicity of Local Anesthetics and Corticosteroids on Chondrocyte and Synoviocyte Viability and Metabolism. Cartilage. 2015 Oct;6(4):233-40. doi: 10.1177/1947603515594453. PMID: 26425261; PMCID: PMC4568732.
Copy Download .nbib Format: NLM
Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient.

CEN case reports

Kanai H, Kobayashi A, Matsushita K, Sawanobori E, Sugita K, Higashida K.
PMID: 28509230
CEN Case Rep. 2013 May;2(1):117-122. doi: 10.1007/s13730-012-0056-8. Epub 2013 Jan 12.

Henoch-Schönlein purpura (HSP) is a common self-limited vasculitis in children. The long-term prognosis depends on renal involvement. In severe Henoch-Schönlein purpura nephritis (HSPN) patients, >50 % have crescent formation and nephrotic syndrome that are important predicted outcomes. Therefore, for...

Cite
Kanai H, Kobayashi A, Matsushita K, et al. Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient. CEN Case Rep. 2013;2(1):117-122doi: 10.1007/s13730-012-0056-8.
Kanai, H., Kobayashi, A., Matsushita, K., Sawanobori, E., Sugita, K., & Higashida, K. (2013). Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient. CEN case reports, 2(1), 117-122. https://doi.org/10.1007/s13730-012-0056-8
Kanai, Hiroaki, et al. "Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient." CEN case reports vol. 2,1 (2013): 117-122. doi: https://doi.org/10.1007/s13730-012-0056-8
Kanai H, Kobayashi A, Matsushita K, Sawanobori E, Sugita K, Higashida K. Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient. CEN Case Rep. 2013 May;2(1):117-122. doi: 10.1007/s13730-012-0056-8. Epub 2013 Jan 12. PMID: 28509230; PMCID: PMC5411523.
Copy Download .nbib Format: NLM
Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation.

Transplantation direct

Bouatou Y, Bacchi VF, Villard J, Moll S, Martin PY, Hadaya K.
PMID: 27500215
Transplant Direct. 2015 Mar 26;1(2):e9. doi: 10.1097/TXD.0000000000000518. eCollection 2015 Mar.

Risk for atypical hemolytic uremic syndrome (aHUS) recurrence after renal transplantation is low with an isolated membrane cofactor protein mutation (MCP). We report the case of a 32-year-old woman with a MCP who underwent kidney transplantation with a good...

Cite
Bouatou Y, Bacchi VF, Villard J, et al. Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation. Transplant Direct. 2015;1(2):e9doi: 10.1097/TXD.0000000000000518.
Bouatou, Y., Bacchi, V. F., Villard, J., Moll, S., Martin, P. Y., & Hadaya, K. (2015). Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation. Transplantation direct, 1(2), e9. https://doi.org/10.1097/TXD.0000000000000518
Bouatou, Yassine, et al. "Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation." Transplantation direct vol. 1,2 (2015): e9. doi: https://doi.org/10.1097/TXD.0000000000000518
Bouatou Y, Bacchi VF, Villard J, Moll S, Martin PY, Hadaya K. Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation. Transplant Direct. 2015 Mar 26;1(2):e9. doi: 10.1097/TXD.0000000000000518. eCollection 2015 Mar. PMID: 27500215; PMCID: PMC4946455.
Copy Download .nbib Format: NLM
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.

World journal of clinical cases

Hamed SA.
PMID: 26090374
World J Clin Cases. 2015 Jun 16;3(6):525-32. doi: 10.12998/wjcc.v3.i6.525.

We describe an unusual clinical and diagnostic feature of a patient with multiple sclerosis (MS). A 25-year-old woman was admitted to the Neurology department (December 2009) with one month history of rapid cognitive deterioration. She had poor cognition, dysphasia,...

Cite
Hamed SA. Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions. World J Clin Cases. 2015;3(6):525-32doi: 10.12998/wjcc.v3.i6.525.
Hamed, S. A. (2015). Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions. World journal of clinical cases, 3(6), 525-32. https://doi.org/10.12998/wjcc.v3.i6.525
Hamed, Sherifa A. "Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions." World journal of clinical cases vol. 3,6 (2015): 525-32. doi: https://doi.org/10.12998/wjcc.v3.i6.525
Hamed SA. Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions. World J Clin Cases. 2015 Jun 16;3(6):525-32. doi: 10.12998/wjcc.v3.i6.525. PMID: 26090374; PMCID: PMC4468900.
Copy Download .nbib Format: NLM
Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.

Clinical ophthalmology (Auckland, N.Z.)

Higashiyama T, Nishida Y, Ohji M.
PMID: 27143850
Clin Ophthalmol. 2016 Apr 20;10:721-9. doi: 10.2147/OPTH.S105096. eCollection 2016.

PURPOSE: To characterize the relationship between inflammation and swelling of extraocular muscles in thyroid-associated ophthalmopathy before and after methylprednisolone pulse therapy.METHODS: The signal intensities and volumes of the superior rectus (SR), inferior rectus (IR), lateral rectus (LR), medial rectus...

Cite
Higashiyama T, Nishida Y, Ohji M. Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy. Clin Ophthalmol. 2016;10:721-9doi: 10.2147/OPTH.S105096.
Higashiyama, T., Nishida, Y., & Ohji, M. (2016). Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy. Clinical ophthalmology (Auckland, N.Z.), 10721-9. https://doi.org/10.2147/OPTH.S105096
Higashiyama, Tomoaki, et al. "Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy." Clinical ophthalmology (Auckland, N.Z.) vol. 10 (2016): 721-9. doi: https://doi.org/10.2147/OPTH.S105096
Higashiyama T, Nishida Y, Ohji M. Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy. Clin Ophthalmol. 2016 Apr 20;10:721-9. doi: 10.2147/OPTH.S105096. eCollection 2016. PMID: 27143850; PMCID: PMC4844430.
Copy Download .nbib Format: NLM
The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries.

Revista brasileira de ortopedia

do Vale Ramos RC, Alegrete N.
PMID: 27218071
Rev Bras Ortop. 2015 Oct 01;50(6):617-24. doi: 10.1016/j.rboe.2015.09.001. eCollection 2015.

The aim here was to conduct a review of the literature on pharmacological therapies for modifying the neurological status of patients with spinal cord injuries. The PubMed database was searched for articles with the terms "spinal cord injury AND...

Cite
do Vale Ramos RC, Alegrete N. The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries. Rev Bras Ortop. 2015;50(6):617-24doi: 10.1016/j.rboe.2015.09.001.
do Vale Ramos, R. C., & Alegrete, N. (2015). The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries. Revista brasileira de ortopedia, 50(6), 617-24. https://doi.org/10.1016/j.rboe.2015.09.001
do Vale Ramos, Renato Carlos, and Alegrete, Nuno. "The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries." Revista brasileira de ortopedia vol. 50,6 (2015): 617-24. doi: https://doi.org/10.1016/j.rboe.2015.09.001
do Vale Ramos RC, Alegrete N. The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries. Rev Bras Ortop. 2015 Oct 01;50(6):617-24. doi: 10.1016/j.rboe.2015.09.001. eCollection 2015. PMID: 27218071; PMCID: PMC4866940.
Copy Download .nbib Format: NLM
Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction.

Experimental and therapeutic medicine

Zhou Y, Yu Y, Tang Z, Li S, Hu W, Luo C, Liu Z.
PMID: 26668625
Exp Ther Med. 2015 Dec;10(6):2253-2258. doi: 10.3892/etm.2015.2799. Epub 2015 Oct 14.

The aim of the present study was to evaluate the clinical efficacy of peritoneal dialysis (PD) in patients with severe lupus nephritis (LN) complicated with organ dysfunction. In total, 13 severe LN patients complicated with multiple-organ dysfunction, who underwent...

Cite
Zhou Y, Yu Y, Tang Z, et al. Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction. Exp Ther Med. 2015;10(6):2253-2258doi: 10.3892/etm.2015.2799.
Zhou, Y., Yu, Y., Tang, Z., Li, S., Hu, W., Luo, C., & Liu, Z. (2015). Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction. Experimental and therapeutic medicine, 10(6), 2253-2258. https://doi.org/10.3892/etm.2015.2799
Zhou, Yan, et al. "Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction." Experimental and therapeutic medicine vol. 10,6 (2015): 2253-2258. doi: https://doi.org/10.3892/etm.2015.2799
Zhou Y, Yu Y, Tang Z, Li S, Hu W, Luo C, Liu Z. Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction. Exp Ther Med. 2015 Dec;10(6):2253-2258. doi: 10.3892/etm.2015.2799. Epub 2015 Oct 14. PMID: 26668625; PMCID: PMC4665972.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Chebane L, Tavassoli N, Bagheri H, Jean-LouisMontastruc.
PMID: 27393246
Therapie. 2010 Sep-Oct;65(5):447-58. doi: 10.2515/therapie/2010051.

OBJECTIVE: To analyse drugs inducing hyperglycemia by using data reported to the French spontaneous reporting system and recorded in the French PharmacoVigilance Database (FPVD).METHODS: All cases with a report of hyperglycemia and/or diabetes in the French database between 1985...

Cite
Chebane L, Tavassoli N, Bagheri H, et al. Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie. 2010;65(5):447-58doi: 10.2515/therapie/2010051.
Chebane, L., Tavassoli, N., Bagheri, H., Jean-LouisMontastruc. (2010). Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie, 65(5), 447-58. https://doi.org/10.2515/therapie/2010051
Chebane, Leila, et al. "Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV)." [Not Available]. Therapie vol. 65,5 (2010): 447-58. doi: https://doi.org/10.2515/therapie/2010051
Chebane L, Tavassoli N, Bagheri H, Jean-LouisMontastruc. Hyperglycémies d'origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). [Not Available]. Therapie. 2010 Sep-Oct;65(5):447-58. doi: 10.2515/therapie/2010051. French. PMID: 27393246.
Copy Download .nbib Format: NLM
Autoimmune encephalopathy and drug refractory seizures with the presence of two autoantibodies specific for the neuronal cell surface.

Epilepsy & behavior case reports

Al-Ajlan FS, Althobiti A, Baz S, Al-Attas A.
PMID: 25667907
Epilepsy Behav Case Rep. 2014 Nov 27;2:199-202. doi: 10.1016/j.ebcr.2014.06.002. eCollection 2014.

BACKGROUND: An increasing number of autoantibodies are being described in epilepsy and other seizure-related disorders. A pathogenic role of autoantibodies in epilepsy has been suggested based on observations of the efficacy of immunotherapy.OBJECTIVE: This study aimed to report a...

Cite
Al-Ajlan FS, Althobiti A, Baz S, et al. Autoimmune encephalopathy and drug refractory seizures with the presence of two autoantibodies specific for the neuronal cell surface. Epilepsy Behav Case Rep. 2014;2:199-202doi: 10.1016/j.ebcr.2014.06.002.
Al-Ajlan, F. S., Althobiti, A., Baz, S., & Al-Attas, A. (2014). Autoimmune encephalopathy and drug refractory seizures with the presence of two autoantibodies specific for the neuronal cell surface. Epilepsy & behavior case reports, 2199-202. https://doi.org/10.1016/j.ebcr.2014.06.002
Al-Ajlan, Fahad S, et al. "Autoimmune encephalopathy and drug refractory seizures with the presence of two autoantibodies specific for the neuronal cell surface." Epilepsy & behavior case reports vol. 2 (2014): 199-202. doi: https://doi.org/10.1016/j.ebcr.2014.06.002
Al-Ajlan FS, Althobiti A, Baz S, Al-Attas A. Autoimmune encephalopathy and drug refractory seizures with the presence of two autoantibodies specific for the neuronal cell surface. Epilepsy Behav Case Rep. 2014 Nov 27;2:199-202. doi: 10.1016/j.ebcr.2014.06.002. eCollection 2014. PMID: 25667907; PMCID: PMC4307881.
Copy Download .nbib Format: NLM
Ayurvedic management of life-threatening skin emergency erythroderma: A case study.

Ayu

Singh SK, Rajoria K.
PMID: 26730142
Ayu. 2015 Jan-Mar;36(1):69-72. doi: 10.4103/0974-8520.169015.

Erythroderma or generalized exfoliative dermatitis is a skin disorder that requires attention equivalent to medical emergencies. It is more prevalent in male population. It accounts for 35 cases/100,000 cases in dermatologic outpatient departments. In erythroderma even with proper management...

Cite
Singh SK, Rajoria K. Ayurvedic management of life-threatening skin emergency erythroderma: A case study. Ayu. 2015;36(1):69-72doi: 10.4103/0974-8520.169015.
Singh, S. K., & Rajoria, K. (2015). Ayurvedic management of life-threatening skin emergency erythroderma: A case study. Ayu, 36(1), 69-72. https://doi.org/10.4103/0974-8520.169015
Singh, Sarvesh Kumar, and Rajoria, Kshipra. "Ayurvedic management of life-threatening skin emergency erythroderma: A case study." Ayu vol. 36,1 (2015): 69-72. doi: https://doi.org/10.4103/0974-8520.169015
Singh SK, Rajoria K. Ayurvedic management of life-threatening skin emergency erythroderma: A case study. Ayu. 2015 Jan-Mar;36(1):69-72. doi: 10.4103/0974-8520.169015. PMID: 26730142; PMCID: PMC4687243.
Copy Download .nbib Format: NLM
Kawasaki Disease and Peripheral Gangrene in Infancy.

Iranian journal of pediatrics

Malekzadeh I, Ziaee V, Sadrosadat T, Moardinejad MH, Sayadpour-Zanjani K.
PMID: 26635941
Iran J Pediatr. 2015 Dec;25(6):e3309. doi: 10.5812/ijp.3309. Epub 2015 Dec 23.

INTRODUCTION: Early diagnosis and treatment of Kawasaki disease as the most common cause of acquired heart disease in childhood, may significantly improve the prognosis. Diagnosing infantile Kawasaki (younger than a year) is difficult because of obscure symptoms; at the...

Cite
Malekzadeh I, Ziaee V, Sadrosadat T, et al. Kawasaki Disease and Peripheral Gangrene in Infancy. Iran J Pediatr. 2015;25(6):e3309doi: 10.5812/ijp.3309.
Malekzadeh, I., Ziaee, V., Sadrosadat, T., Moardinejad, M. H., & Sayadpour-Zanjani, K. (2015). Kawasaki Disease and Peripheral Gangrene in Infancy. Iranian journal of pediatrics, 25(6), e3309. https://doi.org/10.5812/ijp.3309
Malekzadeh, Iran, et al. "Kawasaki Disease and Peripheral Gangrene in Infancy." Iranian journal of pediatrics vol. 25,6 (2015): e3309. doi: https://doi.org/10.5812/ijp.3309
Malekzadeh I, Ziaee V, Sadrosadat T, Moardinejad MH, Sayadpour-Zanjani K. Kawasaki Disease and Peripheral Gangrene in Infancy. Iran J Pediatr. 2015 Dec;25(6):e3309. doi: 10.5812/ijp.3309. Epub 2015 Dec 23. PMID: 26635941; PMCID: PMC4662841.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2299 entries